ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter ...

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look ...

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

Hims & Hers will begin selling branded GLP-1 weight loss drugs from Eli Lilly. The FDA recently ended the company's temporary permission to compound similar GLP-1 drugs, which was set to take a ...

Hims & Hers Health, Inc. (HIMS) closed the latest trading day at $27.23, indicating a +1.57% change from the previous session's end. The stock fell short of the S&P 500, which registered a gain of ...

Hims & Hers Health Inc.’s shares jumped Tuesday after it said it was broadening its weight-loss offerings, adding access to brand name shots like Zepbound after previously focusing on cheaper ...

The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform.